PubMed Willard, F.S., Douros, J.D., Gabe, M.B., Showalter, A.D., Wainscott, D.B., Suter, T.M., Capozzi, M.E., van der Velden, W.J., Stutsman, C., Cardona, G.R., Urva, S., Emmerson, P.J., Holst, J.J., DAlessio, D.A., Coghlan, M.P., Rosenkilde, M.M., Campbell, J.E., & Sloop, K.W
Read the revised labels for all changes and additions
Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control
Dosing should be individualized and titrated according to clinical response, typically starting at 30 mg three times daily and increasing in 30 mg increments every 23 days to a target range of 60120 mg per dose every 36 hours
A properly reconstituted peptide solution is typically: Clear and transparent Free of visible particles Without floating debris Without persistent cloudiness Uniform throughout the vial If undissolved particles remain after allowing additional time for dissolution, avoid vigorous shaking
miltiorrhiza s most physiologically active ingredients, SalB , modulates TGF-, PAR1, and oxidative stress to produce anti-fibrotic actions (Figure 4)